New Insights into Irritable Bowel Syndrome
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: 26 October 2024 | Viewed by 64
Special Issue Editors
Interests: disorders of gut-brain interaction; irritable bowel syndrome; eosinophilic gastrointestinal disorders; diarrhoea; abdominal pain; high-resolution manometry
Interests: disorders of gut-brain interaction; irritable bowel syndrome; FODMAPs; low-FODMAPs diet; anorectal manometry; chronic constipation; functional dyspepsia; gastroparesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
Irritable bowel syndrome (IBS) is a highly prevalent gastrointestinal disease that represents a significant cause of morbidity worldwide. The disease significantly affects patients’ quality of life, work productivity and social functioning. The pathophysiology of IBS is not completely understood and its diagnosis should be made based on the Rome IV criteria. Nevertheless, the severity of the patient’s symptoms and concerns sometimes drives the physician to perform useless and/or expensive diagnostic tests, transforming IBS into a diagnosis of exclusion. Therefore, a deeper knowledge of IBS mechanisms is mandatory to improve the management of the disease. Conventional treatments include lifestyle changes, diets, probiotics, laxatives, antidiarrhoeals and antispasmodics. More recently, other therapies have been investigated in randomized controlled trials and observational studies, including faecal microbiota transplantation, central neuromodulators, intestinal secretagogues, drugs acting on opioid or 5-HT receptors, minimally absorbed antibiotics, and psychological therapies.
The scientific community will certainly benefit from updated reviews focusing on the optimal management of IBS. In this Special Issue, we invite you to submit your updated review addressing the management aspects and/or therapeutics of IBS.
We look forward to your contribution relating to this cutting-edge Special Issue of the Journal of Clinical Medicine.
Dr. Pierfrancesco Visaggi
Prof. Dr. Massimo Bellini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- irritable bowel syndrome
- management
- disorders of gut–brain interactions
- neuromodulators
- fecal microbiota
- probiotics
- diet
- FODMAPs
- intestinal secretagogues
- 5-HT receptors
